prostate-cancer

Documents about prostate-cancer

• Machine Learning Classification of Prostate Cancer Genomic Sequences Using K-Mer and Sequence-Derived Features#477024ODU Digital Commons
• Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis#668726bioRxiv / medRxiv
• First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer#802081ClinicalTrials.gov
• Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau#841966ClinicalTrials.gov
• AZD8186 First Time In Patient Ascending Dose Study#840433ClinicalTrials.gov
• Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.#804585ClinicalTrials.gov
• Genetic Polymorphisms and Antioxidant Reactions in Prostate Cancer.#140439NCBI PubMed Central
• Hypofractionated radiotherapy for prostate cancer: a bibliometric analysis.#157128NCBI PubMed Central
• Infective Complications in TP Biopsy Without Antibiotic Prophylaxis#226312ClinicalTrials.gov
• Induced proximity-based therapeutics for advanced prostate cancer.#458631NCBI PubMed Central
• Chronic Radiation Induced Bowel Toxicity Study#807776ClinicalTrials.gov
• Phase II Study of BI 2536 in Prostate Cancer#810871ClinicalTrials.gov
• Intensity Modulated Radiation Therapy - Prostate Cancer#825089ClinicalTrials.gov
• Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC#832303ClinicalTrials.gov
• Evaluating Tolerability of ePUHRT With Brachytherapy Boost#845311ClinicalTrials.gov
• Quantitative imaging for predicting biological response in 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer#374353HAL (France)
• A Retrospective Review of Low- and Intermediate-Prostate Cancer Patients Treated with Brachytherapy at Chris Hani Baragwanath Academic Hospital#394011WIReDSpace
• Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis#665173HAL (France)
• A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)#842198ClinicalTrials.gov
• Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases#265686PLOS
• Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management#630583IRIS
• Effectiveness of Care in Certified Cancer Centres in Germany#806143ClinicalTrials.gov
• Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study#830038ClinicalTrials.gov
• Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors#812225ClinicalTrials.gov
• Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients#810128ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)#829371ClinicalTrials.gov
• Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis#202781IRIS
• Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling#456035Spiral
• Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients#274698IRIS
• Pharmaceutical Management in Targeted Radioligand Therapy#837227ClinicalTrials.gov
• Rapid progression of prostate cancer in men with a BRCA2 mutation#814596eScholarship
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)#125900ClinicalTrials.gov
• Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study#844814ClinicalTrials.gov
• Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer Theranostics.#9166NCBI PubMed Central
• Prostate cancer risk among French farmers in the AGRICAN cohort#159362HAL (France)
• Germline polygenic score for prostate cancer aggressiveness#267882bioRxiv / medRxiv
• Early-access Use of Radioligand Therapy in Prostate Cancer#288064HAL (France)
• Effect of Casodex on Tumour Hypoxia - Prostate Cancer#802564ClinicalTrials.gov
• Lung Protective Ventilation During Robotic Assisted Prostatectomy#830055ClinicalTrials.gov
• Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial#20079DOAJ
• Long-term outcomes of salvage high-dose-rate brachytherapy for localized recurrence of prostate cancer following definitive radiation therapy: a retrospective analysis#355160OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Radionuclide Therapy of Prostate Cancer Using PSMA Ligands with a 4-Phenylbutyric Acid-Derived Albumin Binder: Recent Chemical and Clinical Advances#424812HAL (France)
• A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer#828228ClinicalTrials.gov
• Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624#838252ClinicalTrials.gov
• Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)#845327ClinicalTrials.gov
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors#812342ClinicalTrials.gov
• Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome#474768ClinicalTrials.gov
• Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival#644905Lund University Publications
• PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT#800281ClinicalTrials.gov